Latest news
SciSparc (Nasdaq: SPRC) launches Phase IIb SCI-110 Tourette study - Stock TitanStock Titan · Wed, 05 Aug 2026 13:00:51 GMTTourette drug candidate enters Phase IIb with prior 21% tic reduction - Stock TitanStock Titan · Wed, 05 Aug 2026 12:22:00 GMTQuantum clinical analytics milestone at SciSparc (Nasdaq: SPRC) - Stock TitanStock Titan · Fri, 31 Jul 2026 07:00:00 GMTNeuroThera's quantum platform takes clinical data to interpretable insights in simulation - Stock TitanStock Titan · Fri, 31 Jul 2026 07:00:00 GMTSciSparc (Nasdaq: SPRC) targets agentic AI, advances quantum platform - Stock TitanStock Titan · Wed, 29 Jul 2026 07:00:00 GMTSciSparc's Quantum Workflow Evaluated on S&P 500 Company Platform - Stock TitanStock Titan · Wed, 29 Jul 2026 07:00:00 GMT